Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 35Leukemia, Lymphocytic, Chronic, B-Cell 26Myelodysplastic Syndromes 11Lymphoma, Mantle-Cell 8Leukemia, Myelomonocytic, Chronic 8Neoplasms 7Burkitt Lymphoma 7Recurrence 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma, B-Cell 5Myeloproliferative Disorders 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia, Biphenotypic, Acute 4Leukemia, B-Cell 4Waldenstrom Macroglobulinemia 3Leukemia 3Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Hematologic Neoplasms 2Hematologic Diseases 2Thrombocytosis 1Thrombocythemia, Essential 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1

Interventions

venetoclax 1Tretinoin 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Promyelocytic, Acute × venetoclax × Clear all
NCT07187505 2025-09-23

Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia

Anhui Medical University

Phase NA Active not recruiting
28 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡